ng-nitroarginine methyl ester has been researched along with Embolism in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belosjorow, S; Büchert, A; Dörge, H; Heusch, G; Konietzka, I; Krüger, A; Martin, C; Schulz, R; Schwanke, U; Thielmann, M; van De Sand, A | 1 |
1 other study(ies) available for ng-nitroarginine methyl ester and Embolism
Article | Year |
---|---|
Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-alpha, and sphingosine.
Topics: Amidohydrolases; Animals; Apoptosis; Blood Flow Velocity; Ceramidases; Coronary Circulation; Coronary Disease; Disease Models, Animal; Dogs; Embolism; Endocannabinoids; Enzyme Inhibitors; Ethanolamines; Leukocyte Count; Microspheres; Myocardial Contraction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oleic Acids; RNA, Messenger; Signal Transduction; Sphingosine; Tumor Necrosis Factor-alpha | 2002 |